REQUEST A DEMO
Total
USD $0.00
Search more companies

Pernix Pharma Kft. (Hungary)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Pernix Pharma Gyogyszergyarto Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Pernix Pharma Kft. is an enterprise based in Hungary. Its main office is in Zalaegerszeg. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. It was first established on October 01, 2000. Pernix Pharma Kft. currently employs 74 (2024) people. The latest financial highlights indicate a net sales revenue increase of 26.85% in 2023. Its’ total assets recorded a growth of 22.4%.

Headquarters
Kamilla utca 3.
Zalaegerszeg; Zala; Postal Code: 8900

Contact Details: Purchase the Pernix Pharma Kft. report to view the information.

Website: http://www.pernixpharma.hu

Basic Information
Total Employees:
Purchase the Pernix Pharma Kft. report to view the information.
Outstanding Shares:
Purchase the Pernix Pharma Kft. report to view the information.
Registered Capital:
Purchase the Pernix Pharma Kft. report to view the information.
Financial Auditors:
Purchase the Pernix Pharma Kft. report to view the information.
Incorporation Date:
October 01, 2000
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Pernix Pharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
26.85%
Total operating revenue
25.05%
Operating profit (EBIT)
-44.19%
EBITDA
11.03%
Net Profit (Loss) for the Period
-99.75%
Total assets
22.4%
Total equity
0.01%
Operating Profit Margin (ROS)
-1.65%
Return on Equity (ROE)
-3.6%
Quick Ratio
0.1%
Cash Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?